Volume 11, Issue 1 e6847
CASE IMAGE
Open Access

Imaging manifestations of small cell neuroendocrine carcinoma of the ureter

Guiwu Chen

Guiwu Chen

Department of Ultrasound, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, Dongguan, China

Search for more papers by this author
Xiong Huang

Xiong Huang

Department of Ultrasound, Dongguan Dongcheng Hospital, Dongguan, China

Search for more papers by this author
Wenqin Liu

Wenqin Liu

Department of Ultrasound, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, Dongguan, China

Search for more papers by this author
Xiaomin Liao

Xiaomin Liao

Department of Pathology, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, Dongguan, China

Search for more papers by this author
Zhizhong He

Zhizhong He

Department of Ultrasound, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, Dongguan, China

Search for more papers by this author
Yuhuan Xie

Corresponding Author

Yuhuan Xie

Department of Ultrasound, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, Dongguan, China

Correspondence

Yuhuan Xie, Department of Ultrasound, Affiliated Dongguan Hospital, Southern Medical University, Dongguan People's Hospital, No. 78, Wandao Road, Dongguan 52300, Guangdong Province, China.

Email: [email protected]

Search for more papers by this author
First published: 23 January 2023

Abstract

Small cell neuroendocrine carcinoma (SCNEC) of the ureter is a rare malignant tumor originating from the metaplasia of urothelial cells. This report presents a case of ureteral SCNEC that was preliminarily disclosed by computed tomography; thereafter, transabdominal ultrasonography, transrectal ultrasonography, and magnetic resonance urography were performed to characterize the mass.

A 35-year-old man with a history of backache and hematuria over 1 week was admitted to our hospital. Transabdominal ultrasonography revealed dilation of the left renal collecting system and upper ureter due to blockage of the lower ureter by a hypoechoic mass. Coincidentally, the mass was located in the pelvic cavity next to the rectum. Transrectal ultrasonography was performed; a thickened lower ureter wall, whose structure was disordered and stiff, and additional details of the mass were obtained (Figure 1). Two days ago, abdominal computed tomography (CT) explored a soft tissue mass of the lower ureter that should be distinguished from tumors in other hospitals (Figure 2). Furthermore, magnetic resonance urography (MRU) suggested that the ureteral mass had a low signal filling defect, which was considered a carcinoma due to the lymph nodes being scattered around it (Figure 3). Ultimately, the patient underwent cystoscopy and surgical excision. Finally, pathological examination performed confirmed small cell neuroendocrine carcinoma (SCNEC) (Figure 4).

Details are in the caption following the image
Ultrasonography of small cell neuroendocrine carcinoma of the ureter. (A) Transabdominal ultrasonography showed a hypoechoic mass located in the lower ureter (arrow) that was uniform on internal echo with an undefined boundary. (B) Transrectal ultrasonography showed that the blood flow of the mass was abundant (arrow), and the ureter wall around it was abnormal.
Details are in the caption following the image
Computed tomography of small cell neuroendocrine carcinoma of the ureter. (A) Plain computed tomography scan showed a soft tissue mass of the lower ureter that was heterogeneous and well-defined, which grew into the bladder cavity (arrow). (B) Enhanced computed tomography showed the soft tissue mass of the lower ureter that was slightly inhomogeneous enhancement (arrow).
Details are in the caption following the image
Magnetic resonance urography of small cell neuroendocrine carcinoma of the ureter. (A) The transverse section showed a mass that occurred in the left ureter (arrow). (B) The sagittal section showed the upper edge of the mass was cup-shaped (arrow).
Details are in the caption following the image
Pathology of small cell neuroendocrine carcinoma of the ureter. (A) Hematoxylin–eosin staining exposed the cells proliferated in a nest shape and grew infiltratively with obvious atypia, the nuclei of which were large and deeply stained. (B) Immunohistochemical staining findings were CD56-positive, Syn-positive, CK-partially positive, TTF-1 partially positive, CK20-negative, GATA3-negative, CgA-negative, and Ki-67 approximately 70% positive.

Small cell neuroendocrine carcinoma of the ureter is a highly malignant tumor originating from the metaplasia of urothelial cells with or without neuroendocrine function.1 Due to its rare nature, ureteral SCNEC is always misdiagnosed or escapes diagnosis in the early stage and has a poor prognosis in the later stage on imaging.2 However, SCNEC is usually detected by CT but rarely by ultrasonography and MRU, which could provide more features of ureteral SCNEC, including its composition, pattern, and blood flow. Imaging manifestations of inverted urothelial papilloma is a noninvasive endophytic urothelial neoplasm occurred in the renal pelvis, ureter, and urinary bladder, which shows iso-intense on T1-weighted images and either iso-intense or slightly higher in intensity on T2-weighted images.3 However, it is not uncommon to mistake SCNEC as other ureteral urothelial carcinomas depending on ultrasonography and MRU, especially high-grade ureteral urothelial carcinoma. In conclusion, abdominal CT cannot be avoided and cystoscopy remains the diagnostic procedure of choice.4

AUTHOR CONTRIBUTIONS

Guiwu Chen wrote the original draft of this clinical image and made the subsequent revisions. Xiong Huang participated in the computed tomography analysis and interpretation. Wenqin Liu and Zhizhong He participated in the ultrasonography and magnetic resonance urography analysis and interpretation. Xiaomin Liao participated in the pathology image analysis and interpretation. Yuhuan Xie assisted in the revision and supervised the overall production of this report.

ACKNOWLEDGMENT

None.

    FUNDING INFORMATION

    No funding was received for this study.

    CONFLICTS OF INTEREST

    The authors declare that there is no conflict of interest.

    CONSENT

    Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.

    DATA AVAILABILITY STATEMENT

    The data used to support the findings of this study are available from the corresponding author upon request.